Business Context and Reporting Period
This Form 8-K is filed by Amedica Corporation (not Sintx Technologies, Inc.) for the reporting period of January 7, 2015. The filing details a comprehensive business review resulting in significant cost-saving measures and executive leadership changes.
Key Financial Metrics and Restructuring Costs
- Workforce Reduction: 25 employees terminated, representing approximately 28% of the total workforce.
- Estimated One-Time Costs: Approximately $600,000 in severance and related restructuring costs expected in Q1 2015.
- Projected Savings: Estimated $2.8 million in annualized cash operating expense savings on a going-forward basis.
- Liquidity and Debt: The filing text does not provide specific values for current cash balances, total debt, or liquidity ratios.
- Revenue and Profit: The filing text does not provide specific revenue or net income figures for the period.
Material Changes and Personnel Actions
- Executive Departure: Gordon Esplin, Vice President of Finance and Principal Accounting Officer, left the company in connection with the staff reduction.
- Executive Appointment: Ty Lombardi was appointed Vice President of Finance and Principal Accounting Officer effective January 9, 2015. He received an option to acquire 25,000 shares at $0.97 per share.
- Stock Option Repricing: The Board approved the repricing of 690,859 non-qualified stock options. The exercise price was reduced from a range of $1.45 to $7.22 down to $0.95 per share. This included options held by the Chief Technology Officer.
Outlook, Risks, and Contingencies
Management anticipates no further material future cash expenditures associated with the workforce reduction beyond the estimated $600,000. However, the filing notes that estimated savings and costs are subject to assumptions and actual results may differ materially. The company acknowledges the risk of incurring additional costs not currently contemplated due to events associated with the reduction.
Investor Verification Checklist
- Verify the actual cash impact of the $600,000 severance cost in the Q1 2015 financial statements.
- Confirm the dilution impact of the 690,859 repriced stock options and the 25,000 new options granted to the new CFO.
- Monitor subsequent filings to assess if the projected $2.8 million in annualized savings is being realized.
- Review the press release (Exhibit 99.1) for additional details on the "Forward-Looking Statements" and specific risks.